Spruce Biosciences received FDA Breakthrough Therapy Designation for TA-ERT in treating San Filippo Syndrome Type B [MPS IIIB]. BTD enables potential rolling BLA submission, Priority Review, and ...

Sennheiser has entered the crowded high-end wireless headphone market with the launch of the HDB 630, a premium over-ear model promising true hi-res audio and 60 hours of battery life. Priced at A$999 ...

Spruce Biosciences' stock surged to record highs after it received an FDA breakthrough designation for the TA-ERT candidate to treat a rare genetic disease.

Sennheiser has thrown down the gauntlet with the announcement of the HDB 630, a hi-res headset with a claimed 60 hours battery life, and that's *WITH* ANC enabled.

He or she will regress to the mean, or what he or she actually is or does. Much the same, I fear that what we are witnessing with the Georgia Bulldogs in 2025 is a regression to the mean. Please allow ...

Taysha Gene Therapies stock surges after FDA alignment on a pivotal Rett Syndrome study. Read the latest analysis on TSHA here.

Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster the buyer’s late-stage pipeline of cancer treatments with a late-stage ...

Genmab to acquire clinical-stage biotechnology company, Merus for USD 8 billion: Copenhagen, Denmark Tuesday, September 30, 2025, 09:00 Hrs [IST] Genmab A/S and Merus N.V. announc ...